India’s First Indigenous H5N1 Vaccine Developed for Poultry

  • 20 Nov 2026

On 20 November 2026, Union Agriculture Minister Shivraj Singh Chouhan dedicated India’s first indigenous inactivated H5N1 vaccine to protect chickens from bird flu to the nation in Bhopal.

  • Developing Institute: Developed by the Bhopal-based 'ICAR-National Institute of High Security Animal Diseases' (NIHSAD), this inactivated vaccine targets the 'Clade 2.3.2.1a' strain of Highly Pathogenic Avian Influenza (HPAI).
  • Mechanism of Inactivated Vaccine: Made from killed or non-replicating viruses, the vaccine triggers an immune response in chickens to protect against the H5N1 virus without causing infection itself.
  • Need for the Vaccine: Previously, no specific commercial vaccine was available in India against Clade 2.3.2.1a of the H5N1 virus. This indigenous vaccine aims to protect poultry from this circulating viral clade in the country.
  • Other Facts
  • ICAR-NIHSAD (Bhopal): Located in Bhopal, Madhya Pradesh, this specialized bio-security institute of the Indian Council of Agricultural Research (ICAR) identified India's first H5N1 outbreak in 2006.
  • Avian Influenza (H5N1): Caused by the Influenza-A virus, this infectious disease can cause up to 100% mortality in poultry; according to WHO data, 1,003 human cases and 479 deaths due to H5N1 have been recorded across 25 countries since 2003.